Grand Journal of Urology
E-ISSN : 2757-7163

Relationship Between Triglyceride-Glucose Index and Erectile Dysfunction in Subjects Without Cardiovascular Disease
Ersan Oflar1, Cennet Yildiz1, Atilla Koyuncu1, Dilay Karabulut1, Fatma Nihan Turhan Caglar1, Mehmet Pisirici1, Hakan Polat2
1Department of Cardiology, University of Health Sciences, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Türkiye
2Department of Urology, University of Health Sciences, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Türkiye
DOI : 10.5505/GJU.2023.18480
Pages : 049-053

Abstract

Objective: Studies have shown that insulin resistance (IR) plays a role in the pathogenesis of erectile dysfunction (ED). Triglyceride-glucose (TyG) index has been found as a reliable marker of IR. In this study, our aim was to investigate the role of TyG index in patients with ED.

Materials and Methods: One hundred six patients with ED (study group) and 54 subjects with normal sexual function (control group) constituted our study population. Erectile function was assessed by using International Index of Erectile Function-5 (IIEF-5) questionnaire. TyG index was calculated for each participant.

Results: ED patient were older, had higher total cholesterol (TC), low- density lipoprotein cholesterol (LDL-C), glucose and triglyceride concentrations and TyG indexes (p<0.001, p<0.001, p<0.001, p=0.036, p=0.026 and p=0.003, respectively). IIEF-5 scores showed a negative correlation with TyG indexes (r= -0.273, p=0.001). Receiver operating characteristic (ROC) curve analysis showed that TyG index cut-off value of 9.03 had 70.3% sensitivity and 65% specificity in predicting mild-to-moderate, moderate, and severe ED. Univariate logistic regression analysis showed that age, TC, LDL-C, and TyG index had predictive values for the identification of the patients who had mild-to-moderate, moderate, and severe ED.

Conclusion: TyG index might be a valuable diagnostic tool for ED, and it might be used in clinical practice for the evaluation of patients.

Introduction

Erectile dysfunction (ED) has a negative influence on the quality of life of patients. Its prevalence shows an association with age, surpassing over 80% in men who are older than 80 years [1]. Although this disorder might have organic or psychological causes, the most common underlying pathology is abnormalities of the penile blood vessels. ED shares the same risk factors for cardiovascular disease (CVD) with similar underlying pathophysiological mechanisms [2]. The relationship between ED and CVD is bidirectional. Studies have shown ED as a predictor of CVD and the presence of CVD has been found to be associated with more severe forms of ED [3]. As such, current guidelines have recommended a detailed examination of ED patients in terms of CVD and risk factors [2]. This approach gives physicians a chance for risk mitigation, early diagnosis, and management of CVD.

Insulin resistance (IR) coexists with the proatherogenic milieu and is a part of the atherogenic process [4]. By affecting systemic factors as well as intimal cells that are involved in atherosclerosis, IR seems to have an important role in plaque formation and progression of ED [5]. IR has been related to decreased nitric oxide production and vasodilatation both of which play a role in the pathogenesis of ED [6]. Men with ED have been shown to have higher levels of homeostatic model assessment insulin resistance (HOMA-IR) index which is the most popular method for the assessment of IR [7]. However, this test is relatively expensive and requires measurement of both serum insulin and glucose levels, which has led researchers to search for alternative methods. Triglyceride-glucose index (TyG index), the calculation of which is based on the measurements of serum triglyceride (TG) and glucose levels, is an easily obtainable and reliable marker for IR. The prognostic utility of the TyG index has been shown in acute coronary syndrome, lower extremity peripheral artery disease, heart failure, fatty liver disease, and stable coronary artery disease [8-12]. In the present study, we aimed to evaluate the TyG indexes of the ED patients and to find whether the TyG index has any predictive value in diagnosing ED.

Materials and Methods

We retrospectively screened data files of the patients who were referred from the urology clinic to the cardiology outpatient clinic of a tertiary hospital between January 2022 and January 2023. One hundred sixty patients constituted our study population. Patients who had a history of percutaneous coronary artery intervention, coronary artery bypass graft operation, diabetes mellitus, peripheral arterial disease, liver failure, renal failure, malignancy, thyroid abnormalities, and hypertension were excluded. Patients were referred from the urology department for the purpose of cardiovascular evaluation. All patients gave informed consent for study participation. The study was approved by the local ethics committee (date: 06.03.2023, decision #: 2023-05-15) and conducted in compliance with The World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects.

Diagnosis of ED was made by using the International Index of Erectile Function-5 (IIEF-5) questionnaire. The questionnaire consists of five Likert-type questions which are scored from one to five, while one point represents severe disease whereas five points indicate normal sexual function. According to the scores obtained by the patients in this questionnaire, the severity of ED was classified into groups of severe (5-7 pts), moderate (8-11 pts), mild-to-moderate (11-16 pts), and mild ED (17-21 pts), while scores ≥22 points indicated normal erectile function. Turkish validation of this questionnaire was made by Turunç et al [13]. Patients who had IIEF-5 scores between 1 and 21 constituted the study group (n=106) and the participants who had IIEF-5 scores between 22 and 25 constituted the control group (n=54).

For fasting blood tests blood samples were taken from the antecubital vein in a sitting position. Collected samples were analyzed for biochemical (AU 2700, Beckman Coulter Inc., California, USA) and complete blood count parameters (Sysmex XE 5000, Sysmex Medical Int., Kobe, Japan). TyG index of each patient was calculated as the natural logarithm of the product of plasma glucose and TG using the following formula: fasting glucose value (mg/dL) x fasting triglyceride value (mg/ dL)/2. Cardiovascular status of the patients was evaluated based on the results of physical examinations, electrocardiograms, and treadmill exercise tests. Medications that influenced heart rate were stopped two days before the exercise test which was performed by using Schiller CS-200, Switzerland device.

Statistical Analysis
Normality of the data was assessed by examining skewness, kurtosis of the data and by use of Kolmogorov-Smirnov test. Since all data showed nonparametric distribution, comparison of two groups was done using Mann-Whitney U test. Categorical data were compared by chi-square test. Quade ANCOVA test was used to compare TyG values of the two groups where age was used as a covariate. Correlations between TyG indexes and IIEF-5 scores were performed using Spearman correlation analysis. ROC curve analysis was conducted to find the cutoff value of TyG index in predicting patients who had mildto- moderate, moderate, and severe ED. Univariate logistic regression analysis was conducted to determine the variables that have a predictive value in diagnosing ED. A p value of less than 0.05 was considered statistically significant. All statistical analyses were conducted by using SPSS Statistics for Windows, Version 25.0 (IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM, USA).

Results

The mean age of the study population was 44.24±7.29 years including 70 (43.8%) smokers, and 41 (25.6%) alcohol users. There were no differences between the two groups in terms of the prevalence of smoking, alcohol consumption, high-density lipoprotein-cholesterol (HDL-C), hemoglobin, creatinine concentrations, leukocyte, and platelet counts. ED patients were older and had higher total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), glucose and triglyceride concentrations, and TyG indexes. According to Quade ANCOVA results, the TyG indexes were higher in ED patients when age was used as a covariate (t=-1.876, p=0.045). The clinical characteristics of the two groups are shown in Table 1. IIEF- 5 scores showed a negative correlation with TyG indexes (r= -0.273, p=0.001).

Table 1. Clinical and demographic characteristics of the study and control groups

A total of 37 patients had IIEF-5 scores under 17 points indicating the presence of mild-to-moderate, moderate, and severe ED. ROC curve analysis showed that cut-off value of 9.03 for TyG index had 70.3% sensitivity and 65% specificity in predicting mild-to-moderate, moderate, and severe ED (AUC: 0.729, p<0.001, 95% CI: 0.634-0.856) (Figure 1). Univariate logistic regression analysis showed that age, TC, LDL-C, and TyG index were the variables that had predictive values for the identification of patients who had mild-to-moderate, moderate, and severe ED (Table 2).

Figure 1. ROC curve analysis of TyG index for predicting mild-moderate, moderate and severe ED

Table 2. Univariate logistic regression for prediction of mildto- moderate, moderate and severe disease

Discussion

Our study has shown that the TyG index is an independent predictor for the presence of ED. Moreover, it had a negative correlation with IIEF-5 scores, with higher values indicating lower IIEF-5 scores. Besides TyG index, parameters of age, TC, and LDL-C were predictors for ED.

Although the HOMA-IR index is widely used in clinical practice, its calculation is based on the measurement of glucose and insulin concentrations. In contrast, the TyG index is calculated as the natural logarithm of the product of fasting plasma glucose and and TG concentrations, both of which can be easily measured and evaluated [14]. Studies have shown that the TyG index is a valuable tool for measuring IR, making it a good alternative to the HOMA-IR index [15,16].

Previous studies evaluated the role of IR in ED and found that IR was associated with ED. Chen et al. demonstrated that insulin resistance correlated with the severity of ED. In that study, patients who had IR had decreased testosterone concentrations and deteriorated endothelial functions emphasizing the pathophysiological link between IR and ED [17]. Similarly, Rey- Valzacchi et al. showed that the addition of metformin treatment to sildenafil decreased the IR and ameliorated the ED in patients with IR [18]. Yilmaz et al. investigated the value of the TyG index in ED patients and found that the cut-off value of 8.88 for the TyG index predicted ED with sensitivity and specificity of 67% and 68.8%, respectively [19]. Li et al. evaluated National Health and Nutrition Examination Survey database to expose the link between the TyG index and ED in general population. They found that the prevalence of ED was increased in subjects who had higher TyG indexes [20]. IR is considered a predictor of prediabetes, and progression to diabetes is associated with the atherosclerotic process [17]. It has been shown that patients with IR had increased levels of sympathetic activity, endothelin-1 concentration, oxidative stress, inflammatory activity, and impaired endothelial function; all of which are thought to play a role in ED [21,22]. Our study was in line with the aforementioned studies in that we also detected higher TyG indexes in ED patients supporting the role of IR in the pathogenesis of ED. In our study, cut-off value of 9.03 for TyG index had 70.3% sensitivity and 65% specificity in predicting the presence of ED. In our study, no patient had a history of ischemic heart disease and all of them had negative treadmill exercise tests.

Although no patient in the current study had a history of ischemic heart disease and cardiovascular risk factors, patients with ED had unfavorable metabolic profiles including increased levels of LDL-C, TC, glucose, triglyceride concentrations, and TyG index values, all of which have been shown to be related to endothelial dysfunction [23]. Patients with ED were older, however, age-adjusted TyG indexes have remained at a higher level in ED patients.

As the limitations of the sudy; our study was a single-center, retrospective study and the sample size was relatively small.

Long-term follow-up of the patients was not done and the effect of lifestyle and medical interventions on TyG index and ED was not assessed.

Conclusion

TyG index, an easily calculable and effective method for assessing IR, had a predictive role in patients with ED. It could be used in clinical practice to evaluate the cardiovascular status of ED patients.

Ethics Committee Approval: The protocol of the present study was reviewed and approved by the Institutional Review Board of University of Health Sciences Dr. Sadi Konuk Training and Research Hospital (date: 06.03.2023, decision #: 2023-05-15).

Informed Consent: An informed consent was obtained from all the patients.

Publication: The results of the study were not published in full or in part in form of abstracts.

Peer-review: Externally and internally peer-reviewed.

Authorship Contributions: Any contribution was not made by any individual not listed as an author. Concept - E.O., C.Y., H. P.; Design - E.O., C.Y., H. P.; Supervision - E.O., C.Y., H. P.; Resources - A. K., D. K., M. P.; Materials - A. K., D. K., M. P.; Data Collection and/or Processing - A. K., D. K., M. P.; Analysis and/or Interpretation - E.O., C.Y., H. P.; Literature Search – A. K., D. K., M. P.; Writing Manuscript - E.O., C.Y., F. N. T. C.; Critical Review - E.O., C.Y., F. N. T. C., H. P.

Conflict of Interest: The authors declare that they have no conflicts of interest.

Financial Disclosure: The authors state that they have not received any funding.

Reference

1) Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JL. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res 2002;14:422-32. https://doi.org/10.1038/sj.ijir.3900905

2) Hackett G, Kirby M, Wylie K, Heald A, Ossei-Gerning N, Edvards D, et al. British society for sexual medicine guidelines on the management of erectile dysfunction in men-2017. J Sex Med 2018;15:430-57. https://doi.org/10.1016/j.jsxm.2018.01.023

3) Zhao B, Hong Z, Wei Y, Yu D, Xu J, Zhang W. Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and metaanalysis. J Sex Med 2019;16:1005-17. https://doi.org/10.1016/j.jsxm.2019.04.004

4) Beverly JK, Budoff MJ. Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation J Diabetes 2020;12:102-4.10.1111/1753- 0407.12970

5) Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis Cell Metab 2011;14:575-85. https://doi.org/10.1016/j.cmet.2011.07.015

6) Trussell JC, Legro RS. Erectile dysfunction: does insulin resistance play a part? Fertil Steril 2007;88:771-8. https://doi.org/10.1016/j.fertnstert.2007.01.116

7) Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001;24:362-5. https://doi.org/10.2337/diacare.24.2.362

8) Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease J Thorac Dis 2018;10:6137-46. https://doi.org/10.21037/jtd.2018.10.79

9) Wang J, Yan Si, Cui Y, Chen F, Piao M, Cui W. The diagnostic and prognostic value of the triglyceride-glucose index in metabolic dysfunction-associated fatty liver disease (MAFLD): a systematic review and meta-analysis. Nutrients 2022;14:4969. https://doi.org/10.3390/nu14234969

10) Huang R, Wang Z, Chen J, Bao X, Xu N, Guo S, et al. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. Cardiovasc Diabetol 2022;21:88. https://doi.org/10.1186/s12933-022-01507-7

11) Akbar MR, Pranata R, Wibowo A, Irvan, Sihite TA, Martha JW. The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome-dose-response meta-analysis Nutr Metab Cardiovasc Dis 2021;31:3024-30. https://doi.org/10.1016/j.numecd.2021.08.026

12) Pala AA, Urcun YS. Relationship of triglyceride-glucose index with chronic limb-threatening ischemia in lower extremity peripheral artery disease Vascular. 2022;30:455-62. https://doi.org/10.1177/17085381211018332

13) Turunç T, Deveci S, Güvel S, Peşkircioğlu S. The Assessment of Turkish Validation with 5 Question Version of International Index of Erectile Function (IIEF-5). Turk J Urol 2007;33:45-9. https://search.trdizin.gov.tr/tr/yayin/detay/71538/

14) Unger G, Benozzi SF, Perruzza F, Pennacchiotti GL. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr 2014;61:533-40. https://doi.org/10.1016/j.endonu.2014.06.009

15) Toro-Huamanchumo CJ, Urrunaga-Pastor D, Guarnizo- Poma M, Lazaro-Alcantara H, Paico-Palacios S, Pantoja- Torres B, et al. Triglycerides and glucose index as an insulin resistance marker in a sample of healthy adults. Diabetes Metab Syndr 2019;13:272-77. https://doi.org/10.1016/j.dsx.2018.09.010

16) Lee SB, Kim MK, Kang S, Park K, Kim JH, Baik SJ, et al. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults. Endocrinol Metab (Seoul) 2019;34:179-86. https://doi.org/10.3803/EnM.2019.34.2.179

17) Chen S, Wu R, Huang Y, Zheng F, Ou Y, Tu X, et al. Insulin resistance is an independent determinate of ED in young adult men. PLoS One 2013;8:e83951. https://doi.org/10.1371/journal.pone.0083951

18) Rey-Valzacchi GJ, Costanzo PR, Finger LA, Layus AO, Gueglio GM, Litwak LE, et al. Addition of metformin to sildenafil treatment for erectile dysfunction in eugonadal nondiabetic men with insulin resistance. A prospective, randomized, double-blind pilot study. J Androl 2012;33:608-14. https://doi.org/10.2164/jandrol.111.013714

19) Yilmaz M, Karaaslan M, Tonyali S, Celik M, Toprak T, Odabas O. Triglyceride-Glucose Index (TyG) is associated with erectile dysfunction: A cross-sectional study Andrology 2021;9:238-44. https://doi.org/10.1111/andr.12904

20) Li L, Yao H, Dai W, Chen Y, Liu H, Ding W, et al. A higher TyG index is related with a higher prevalence of erectile dysfunction in males between the ages 20-70 in the United States, according to a cross-sectional research. Front Endocrinol (Lausanne) 2022;13:988257. https://doi.org/10.3389/fendo.2022.988257

21) Aljada A, Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 2000;49:147-150. https://doi.org/10.1016/s0026-0495(00)91039-4

22) Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006;22:423-36. https://doi.org/10.1002/dmrr.634

23) Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005;23:233-46. https://doi.org/10.1097/00004872-200502000-00001

Keywords : erectile dysfunction, triglyceride, glucose

Viewed : 1213
Downloaded : 274